Found: 12
Select item for more details and to access through your institution.
Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5788, doi. 10.3390/ijms21165788
- By:
- Publication type:
- Article
Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.
- Published in:
- Journal of Biomedical Research, 2018, v. 32, n. 2, p. 81, doi. 10.7555/JBR.31.20160124
- By:
- Publication type:
- Article
At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1577, doi. 10.3390/cancers14061577
- By:
- Publication type:
- Article
CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1128, doi. 10.3390/cancers11081128
- By:
- Publication type:
- Article
Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 423, doi. 10.1002/1878-0261.12167
- By:
- Publication type:
- Article
Nanoparticles Loaded with Wnt and YAP/Mevalonate Inhibitors in Combination with Paclitaxel Stop the Growth of TNBC Patient‐Derived Xenografts and Diminish Tumorigenesis.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 11, p. 1, doi. 10.1002/adtp.202000123
- By:
- Publication type:
- Article
Inhibition of the TGF‐beta Pathway Enhances the Tumoricidal Effect of Doxorubicin on Breast Cancer Cells.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.05258
- By:
- Publication type:
- Article
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41419-020-03308-w
- By:
- Publication type:
- Article
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 8, p. 1, doi. 10.1038/s41419-018-0811-7
- By:
- Publication type:
- Article
Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC.
- Published in:
- Biomedicines, 2021, v. 9, n. 10, p. 1386, doi. 10.3390/biomedicines9101386
- By:
- Publication type:
- Article
Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition.
- Published in:
- FEBS Letters, 2016, v. 590, n. 24, p. 4606, doi. 10.1002/1873-3468.12496
- By:
- Publication type:
- Article
Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1366197
- By:
- Publication type:
- Article